-
公开(公告)号:US20240058447A1
公开(公告)日:2024-02-22
申请号:US18323342
申请日:2023-05-24
IPC分类号: A61K39/00 , A61K38/17 , A61K39/395 , C07K14/705 , A61P35/00
CPC分类号: A61K39/464482 , A61K38/1774 , A61K39/39558 , A61K39/4611 , A61K39/4631 , A61K39/464468 , C07K14/70521 , C07K14/70578 , A61K38/1793 , A61P35/00 , C07K2319/03 , C07K2317/622 , A61K2039/505
摘要: Provided herein are methods employing various fusion constructs in T cell therapy. The fusion constructs allow for one to reduce, to the point of full removal if desired, the use of IL-2 that would otherwise accompany an in vivo T cell therapy.